Preoperative body mass index, blood albumin and triglycerides predict survival for patients with gastric cancer

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Liu, Bin Zheng ^a,c   Tao, Lin ^a   Chen, Yun Zhao ^a   Li, Xu Zhe ^a   Dong, Yu Ling ^a   Ma, Ya Jing ^a   Li, Shu Gang ^a   Li, Feng ^a,b   Zhang, Wen Jie ^a  

^a SHIHEZI UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM ALBUMIN; TRIACYLGLYCEROL;

ADULT; AGED; BLOOD; BODY MASS; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; PROGNOSIS; SERUM ALBUMIN; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TRIGLYCERIDES;

EID: 84995519189     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157401     Document Type: Article

References (40)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2):87-108. Epub 2015/02/06. doi: 10.3322/caac.21262 PMID: 25651787.
2. Chen WQ, Zhang RS, Zhang SW, Zeng HM, Zuo TT, Jia MM, et al. Report of cancer incidence and mortality in china, 2012. China Cancer. 2016. doi: 10.11735/j.issn.1004-0242.2016.01.A001
3. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016. Epub 2016/01/26. doi: 10.3322/caac.21338 PMID: 26808342.
4. Pasini F, Fraccon AP, DE Manzoni G. The role of chemotherapy in metastatic gastric cancer. Anticancer Res. 2011; 31(10):3543-54. Epub 2011/10/04. PMID: 21965776.
5. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010; 17 (12):3077-9. Epub 2010/10/01. doi: 10.1245/s10434-010-1362-z PMID: 20882416.
6. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011; 14(2):113-23. Epub 2011/05/17. doi: 10.1007/s10120-011-0042-4 PMID: 21573742.
7. Thrumurthy SG, Chaudry MA, Hochhauser D, Mughal M. The diagnosis and management of gastric cancer. BMJ. 2013; 347:f6367. Epub 2013/11/06. PMID: 24191271. doi: 10.1136/bmj.f6367
8. Arnold M, Pandeya N, Byrnes G, Renehan AG, Stevens GA, Ezzati M, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015; 16(1):36-46. Epub 2014/12/04. doi: 10.1016/s1470-2045(14)71123-4 PMID: 25467404; PubMed Central PMCID: PMC4314462.
9. Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Islam R, Hortobagyi GN, et al. Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res. 2008; 14(6):1718-25. Epub 2008/03/19. doi: 10.1158/1078-0432.ccr-07-1479 PMID: 18347172.
10. Lianos GD, Bali CD, Glantzounis GK, Katsios C, Roukos DH. BMI and lymph node ratio may predict clinical outcomes of gastric cancer. Future Oncol. 2014; 10(2):249-55. Epub 2014/02/05. doi: 10.2217/ fon.13.188 PMID: 24490611.
11. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010; 16(6):1884-93. Epub 2010/03/11. doi: 10. 1158/1078-0432.ccr-09-2636 PMID: 20215553; PubMed Central PMCID: PMC2948494.
12. Tokunaga M, Hiki N, Fukunaga T, Ohyama S, Yamaguchi T, Nakajima T. Better 5-year survival rate following curative gastrectomy in overweight patients. Ann Surg Oncol. 2009; 16(12):3245-51. Epub 2009/07/29. doi: 10.1245/s10434-009-0645-8 PMID: 19636624.
13. Bickenbach KA, Denton B, Gonen M, Brennan MF, Coit DG, Strong VE. Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol. 2013; 20 (3):780-7. Epub 2012/09/15. doi: 10.1245/s10434-012-2653-3 PMID: 22976377.
14. Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, Elliott P, et al. A combination of serum low albumin and above-average cholesterol level was associated with excess mortality. J Clin Epidemiol. 2004; 57(11):1188-95. Epub 2004/12/23. PMID: 15612140.
15. Kawut SM, Horn EM, Berekashvili KK, Garofano RP, Goldsmith RL, Widlitz AC, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol. 2005; 95(2):199-203. Epub 2005/ 01/12. doi: 10.1016/j.amjcard.2004.09.006 PMID: 15642552.
16. Tateishi R, Yoshida H, Shiina S, Imamura H, Hasegawa K, Teratani T, et al. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut. 2005; 54(3):419-25. Epub 2005/02/16. doi: 10.1136/gut.2003.035055 PMID: 15710994; PubMed Central PMCID: PMC1774402.
17. Schindl M, Wigmore SJ, Currie EJ, Laengle F, Garden OJ. Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg. 2005; 140(2):183-9. Epub 2005/02/23. doi: 10. 1001/archsurg.140.2.183 PMID: 15724001.
18. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade J, et al. International staging system for multiple myeloma. J Clin Oncol. 2005; 23(15):3412-20. Epub 2005/04/06. doi: 10.1200/jco.2005.04. 242 PMID: 15809451.
19. Ulmer H, Borena W, Rapp K, Klenk J, Strasak A, Diem G, et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer. 2009; 101(7):1202-6. Epub 2009/08/20. doi: 10.1038/sj.bjc.6605264 PMID: 19690552; PubMed Central PMCID: PMC2768093.
20. Martin RM, Vatten L, Gunnell D, Romundstad P, Nilsen TI. Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway. Cancer Causes Control. 2009; 20(7):1181-92. Epub 2009/03/12. doi: 10.1007/s10552-009-9319-x PMID: 19277881.
21. Bei-Fan Z. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr. 2002; 11 Suppl 8:S685-93. Epub 2003/01/22. PMID: 12534691.
22. Zhou BF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases-report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002; 15(3):245-52. Epub 2002/12/26. PMID: 12500665.
23. Zhou B. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi. 2002; 23(1):5-10. Epub 2002/ 05/17. PMID: 12015100.
24. Medical Administration Department of Ministry of Health, P.R.C. National Guide to Clinical Laboratory Procedures ( Third Edition). Nanjing: Southeast University Press; 2006.
25. Hanley JA. Alternative approaches to receiver operating characteristic analyses. Radiology. 1988; 168 (2):568-70. Epub 1988/08/01. doi: 10.1148/radiology.168.2.3393683 PMID: 3393683.
26. Zhao DQ, Chen J, Wu YF, Tian D, Zhou RX. Correlation between Vascular Endothelial Growth Factor and Somatostatin Receptor with Progression and Prognosis in Gastric Cancer. Hepatogastroenterology. 2014; 61(132):1154-8. Epub 2015/07/15. PMID: 26158180.
27. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015; 385(9972):977-1010. Epub 2014/12/04. doi: 10. 1016/s0140-6736(14)62038-9 PMID: 25467588; PubMed Central PMCID: PMC4588097.
28. Cong L, Zhan JQ, Yang L, Zhang W, Li SG, Chen C, et al. Overweight and obesity among low-income Muslim Uyghur women in far western China: correlations of body mass index with blood lipids and implications in preventive public health. PLoS One. 2014; 9(2):e90262. Epub 2014/03/04. doi: 10.1371/ journal.pone.0090262 PMID: 24587304; PubMed Central PMCID: PMC3938656.
29. Chen HN, Chen XZ, Zhang WH, Yang K, Chen XL, Zhang B, et al. The Impact of Body Mass Index on the Surgical Outcomes of Patients With Gastric Cancer: A 10-Year, Single-Institution Cohort Study. Medicine (Baltimore). 2015; 94(42):e1769. Epub 2015/10/27. doi: 10.1097/md.0000000000001769 PMID: 26496304; PubMed Central PMCID: PMC4620840.
30. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005; 165(1):55-61. Epub 2005/01/12. doi: 10.1001/archinte.165.1.55 PMID: 15642875.
31. O'Brien JM Jr., Phillips GS, Ali NA, Lucarelli M, Marsh CB, Lemeshow S. Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury. Crit Care Med. 2006; 34(3):738-44. Epub 2006/03/08. 16521268; PubMed Central PMCID: PMC1868702. PMID: 16521268
32. Yasunaga H, Horiguchi H, Matsuda S, Fushimi K, Hashimoto H, Ayanian JZ. Body mass index and outcomes following gastrointestinal cancer surgery in Japan. Br J Surg. 2013; 100(10):1335-43. Epub 2013/08/14. doi: 10.1002/bjs.9221 PMID: 23939845.
33. Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg. 2009; 250(1):166-72. Epub 2009/06/30. doi: 10.1097/SLA.0b013e3181ad8935 PMID: 19561456.
34. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006; 355 (8):763-78. Epub 2006/08/24. doi: 10.1056/NEJMoa055643 PMID: 16926275.
35. Arques S, Ambrosi P. Human serum albumin in the clinical syndrome of heart failure. J Card Fail. 2011; 17(6):451-8. Epub 2011/06/01. doi: 10.1016/j.cardfail.2011.02.010 PMID: 21624732.
36. Cui J, Liang H, Deng J, Ding X, Pan Y, Wang X, et al. [The impact of preoperative weight loss for gastric cancer patients after gastrectomy]. Zhonghua Wai Ke Za Zhi. 2014; 52(6):409-14. Epub 2014/09/16. PMID: 25219554.
37. Crumley AB, Stuart RC, McKernan M, McMillan DC. Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg. 2010; 34(10):2393-8. Epub 2010/07/06. doi: 10. 1007/s00268-010-0641-y PMID: 20602101.
38. Azab B, Kedia S, Shah N, Vonfrolio S, Lu W, Naboush A, et al. The value of the pretreatment albumin/ globulin ratio in predicting the long-term survival in colorectal cancer. Int J Colorectal Dis. 2013; 28 (12):1629-36. Epub 2013/07/17. doi: 10.1007/s00384-013-1748-z PMID: 23857599.
39. Wu N, Chen G, Hu H, Pang L, Chen Z. Low pretherapeutic serum albumin as a risk factor for poor outcome in esophageal squamous cell carcinomas. Nutr Cancer. 2015; 67(3):481-5. Epub 2015/02/24. doi: 10.1080/01635581.2015.1004726 PMID: 25706773.
40. Lindkvist B, Almquist M, Bjorge T, Stocks T, Borena W, Johansen D, et al. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer Causes Control. 2013; 24(1):107-16. Epub 2012/11/15. doi: 10.1007/s10552-012-0096-6 PMID: 23149498.